EU Drug Market Shift: Synthetics Rise, Overdoses Lower

The European Union is observing a significant transformation within its illicit drug market, as detailed in the EU Drugs Agency's annual report. A primary concern highlighted is the emergence and spread of synthetic opioids, including nitazenes, which are increasingly found in counterfeit medications and street drugs. These substances have been linked to a rise in fatalities in specific countries like England, Wales, and Bulgaria.

Furthermore, the report indicates a substantial reshuffling of drug supply routes. Authorities are witnessing cocaine entering the EU through smaller, less scrutinized ports, while cannabis is reportedly flowing from North America due to overproduction and lower prices. Enforcement agencies are grappling with new trafficking methods, including the use of drones and speedboats, complicating efforts to intercept illicit substances.

Despite these evolving challenges, the overall number of fatal overdoses across EU member states remains considerably lower than in North America. Cannabis continues to be the most widely used drug, followed by cocaine. The agency identified at least 50 new psychoactive substances for the first time in Europe during the past year, underscoring the dynamic nature of the illicit drug trade.